[99] revealed that inhibiting BRD4 led to a decrease in the invasive behaviour of melanoma cells by downregulating MMP‐2 and enhances phagocytosis by myeloid cells via SIRPα downregulation [99]. The gene discussed is MMP2; the disease is melanoma.